210 computer-security-"https:"-"https:"-"https:"-"https:"-"C.N.R" positions at Zintellect
Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
the guidance of a mentor, this opportunity will involve: developing and applying methods in computational biology and artificial intelligence to gather information about gene function in the legume family; using
-
, project assignment, program rules, and availability of the participant. What are the provisions? You will receive a stipend to be determined by AFIT. Stipends are typically based on a participant’s academic
-
, project assignment, program rules, and availability of the participant. What are the provisions? You will receive a stipend to be determined by AFIT. Stipends are typically based on a participant’s academic
-
initiative are encouraged, research directions will be developed in consultation with the mentor to ensure feasibility and alignment with program objectives. The successful candidate will publish research and
-
research and development comprises many technologies related to computation, storage, privacy, security, and analytics that apply broadly across mission areas. Location Washington, D.C. or remote from within
-
twelve-week research appointment, with the possibility to be renewed for additional research periods. Appointments may be extended depending on funding availability, project assignment, program rules, and
-
. Contingencies All awards and active participation in the program are contingent upon security access approval to Oak Ridge National Laboratory, agreement with the Terms of Appointment, and completion of all
-
needs. You will acquire knowledge of regulatory submission processes, MedDRA dictionary applications, CDISC format and safety data structure, and advanced technical skills in data visualization and web
-
Participation Program at the U.S. Food and Drug Administration is an educational and training program designed to provide college students, recent graduates, and university faculty opportunities to connect with
-
disease models. Development of novel genomic methods to assess neurotoxicity associated with AAV-based gene therapies. This research will generate critical safety and efficacy data to inform regulatory